Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion type Assertion NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_head.
- NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion description "[Genotyping of HPC2/ELAC2 variants (S217L, A541T), along with RNASEL variants (R462Q and E541D) was completed in 155 African American sporadic and 88 familial prostate cancer cases, and 296 healthy male controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_provenance.
- NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion evidence source_evidence_literature NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_provenance.
- NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion SIO_000772 18767027 NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_provenance.
- NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion wasDerivedFrom befree-20150227 NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_provenance.
- NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_assertion wasGeneratedBy ECO_0000203 NP673026.RAM0Y1WzUvJq_3wdvxqBPtYHThk0DLTB6-gC9hOpEXfvY130_provenance.